Search results for "Clostridium difficile infection"


 
Results 1 - 10 of about 19 for "Clostridium difficile infection".

Fidaxomicin has higher cure rate for C. difficile than other drug options, meta-analysis finds | ACP Gastroenterology Monthly

The study authors concluded that fidaxomicin could be considered as a first-line therapy for Clostridium difficile infection and that metronidazole should not be recommended.

Fecal transplants by pill noninferior to colonoscopy delivery | ACP Gastroenterology Monthly

The primary outcome of the unblinded, randomized trial was the proportion of patients without recurrent Clostridium difficile infection 12 weeks after fecal transplant.

Spotlight on gastric acid suppressants | ACP Gastroenterology Monthly

Use of gastric acid suppressants was linked with increased risk of recurrent Clostridium difficile infection and of first-time ischemic stroke in recent research.

In C difficile infection, adding IV bezlotoxumab to standard antibiotics reduced recurrence at 12 weeks | ACP Gastroenterology Monthly

A commentary in ACP Journal Club noted that it would be reasonable to consider fidaxomicin or bezlotoxumab in patients at high risk for recurrent Clostridium difficile infection or in those for whom recurrence could have devastating consequences.

Updated guidelines for C. diff infection address fecal transplant, laboratory testing | ACP Gastroenterology Monthly

The guidelines recommend laboratory testing for C. diff only in patients with new-onset, unexplained diarrhea, defined as at least three unformed stools in 24 hours, among other guidance.

December 22, 2017 | ACP Gastroenterology Monthly

ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.

April 28, 2017 | ACP Gastroenterology Monthly

ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.

Previous gastroenteritis may be associated with later risk for IBD | ACP Gastroenterology Monthly

In this Swedish case-control study, any previous GI infection and previous bacterial, parasitic, and viral GI infection were associated with higher risk for inflammatory bowel disease (IBD) versus controls.

February 23, 2018 | ACP Gastroenterology Monthly

ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.

May 26, 2017 | ACP Gastroenterology Monthly

ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.

Result Page: Prev   1   2   Next